Experimental autoimmune oophoritis and α-melanocyte-stimulating hormone

References

• Sakaguchi S, Wing K, Miyara M. Regulatory T cells – a brief history and perspective. Eur. J. Immunol.37(Suppl. 1), 116–123 (2007).
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat. Rev. Immunol.8(7), 523–532 (2008).
   PubMed Web of Science ®Google Scholar
• Forges T, Monnier-Barbarino P, Faure GC, Béné MC. Autoimmunity and antigenic targets in ovarian pathology. Hum. Reprod. Update10(2), 163–175 (2004).
   PubMed Web of Science ®Google Scholar
• Tsigkou A, Marzotti S, Borges L et al. High serum inhibin concentration discriminates auto-immune oophoritis from other forms of primary ovarian insufficiency. J. Clin. Endocrinol. Metab.93(4), 1263–1269 (2008).
   PubMed Web of Science ®Google Scholar
• Koyama K, Hasegawa A, Mochida N, Calongos G. Follicular dysfunction induced by autoimmunity to zona pellucida. Reprod. Biol.5(3), 269–278 (2005).
   PubMedGoogle Scholar
• Koyama K, Hasegawa A. Premature ovarian insufficiency syndrome may be induced by auto-immune reactions to zona pellucida proteins. J. Reproduktionsmed. Endokrinol.3, 96–97 (2006).
   Google Scholar
• Vangelov I, Dineva J, Nikolov G, Lolov S, Ivanova M. Antibodies against granulosa luteinized cells and their targets in women attending IVF program. Am. J. Reprod. Immunol.53(2), 106–112 (2005).
   Google Scholar
• Calongos G, Hasegawa A, Komori S, Koyama K. Harmful effects of anti-zona pellucida antibodies in folliculogenesis, oogenesis, and fertilization. J. Reprod. Immunol.79(2), 148–155 (2009).
   Google Scholar
• Samy ET, Wheeler KM, Roper RJ, Teuscher C, Tung KS. Cutting edge: Auto-immune disease in day 3 thymectomized mice is actively controlled by endogenous disease-specific regulatory T cells. J. Immunol.180(7), 4366–4370 (2008).
   PubMed Web of Science ®Google Scholar
• Altuntas CZ, Johnson JM, Tuohy VK. Auto-immune targeted disruption of the pituitary–ovarian axis causes premature ovarian insufficiency. J. Immunol.177(3), 1988–1996 (2006).
   Google Scholar
• Berberian V, Sánchez S, Sánchez-Borzone M, Attademo AM, Lasaga M, Celis ME. Effect of α-melanotropin hormone on serum levels of luteinizing hormone and progesterone in experimental rat auto-immune oophoritis. Peptides27(9), 2295–2299 (2006).
   Google Scholar
• Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol.6(4), 318–328 (2006).
   PubMed Web of Science ®Google Scholar
• Butts CL, Sternberg EM. Neuroendocrine factors alter host defense by modulating immune function. Cell. Immunol.252(1–2), 7–15 (2008).
   PubMedGoogle Scholar
• Catania A. Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends Neurosci.31(7), 353–360 (2008).
   PubMed Web of Science ®Google Scholar
• Welt CK. Primary ovarian insufficiency a more accurate term for premature ovarian insufficiency. Clin. Endocrinol. (Oxf.)68, 499–509 (2008).
   PubMed Web of Science ®Google Scholar
• Nelson LM. Clinical practice. Primary ovarian insufficiency. N. Engl. J. Med.360(6), 606–614 (2009).
   PubMed Web of Science ®Google Scholar
• Rees M, Purdie D. Premature menopause. In: Management of the Menopause: The Handbook (4th Edition). Royal Society of Medicine Press Ltd., London, UK 142–149 (2006).
   Google Scholar
• Bakalov VK, Anasti JN, Calis KA. Auto-immune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian insufficiency. Fertil. Steril.84, 958–965 (2005).
   PubMed Web of Science ®Google Scholar
• Wittenberger MD, Hagerman RJ, Sherman SL et al. The FMR1 premutation and reproduction. Fertil. Steril.87, 456–465 (2007).
   PubMed Web of Science ®Google Scholar
• Goswami D, Conway GS. Premature ovarian insufficiency. Horm. Res.68(4), 196–202 (2007).
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz P, Persani L. Premature ovarian insufficiency. Orphanet. J. Rare Dis.1, 9 (2006).
   PubMed Web of Science ®Google Scholar
• Rebar RW. Premature ovarian insufficiency. Obstet. Gynecol.113(6), 1355–1363 (2009).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and auto-immune etiologies. Fertil. Steril.91(5), 1707–1711 (2009).
   PubMed Web of Science ®Google Scholar
• Chen S, Sawicka J, Betterle C et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison’s disease, and premature ovarian failure. J. Clin. Endocrinol. Metab.81(5), 1871–1876 (1996).
   PubMed Web of Science ®Google Scholar
• Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr. Rev.18(1), 107–134 (1997).
   PubMed Web of Science ®Google Scholar
• La Marca A, Marzotti S, Brozzetti A et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J. Clin. Endocrinol. Metab.94(10), 3816–3823 (2009).
   PubMed Web of Science ®Google Scholar
• Tuohy VK, Altuntas CZ. Autoimmunity and premature ovarian insufficiency. Curr. Opin. Obstet. Gynecol.19(4), 366–369 (2007).
   PubMed Web of Science ®Google Scholar
• Robertson DM, Hale GE, Jolley D, Fraser IS, Hughes CL, Burger HG. Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age. J. Clin. Endocrinol. Metab.94(1), 138–144 (2009).
   PubMed Web of Science ®Google Scholar
• Welt CK, Falorni A, Taylor AE, Martin KA, Hall JE. Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J. Clin. Endocrinol. Metab.90(5), 3069–3076 (2005).
   PubMed Web of Science ®Google Scholar
• Burger NZ, Johnson JV. Androgen production in women. In: Androgens and Reproductive Aging. Tulandi T, Gelfand MM (Eds). Tayler and Francis, London, UK 1–4 (2006).
   Google Scholar
• Welt CK. Autoimmune oophoritis in the adolescent. Ann. NY Acad. Sci.1135, 118–122 (2008).
   PubMed Web of Science ®Google Scholar
• Meskhi A, Seif MW. Premature ovarian insufficiency. Curr. Opin. Obstet. Gynecol.18(4), 418–426 (2006).
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil. Steril.82(Suppl. 1), S33–S39 (2004).
   Web of Science ®Google Scholar
• Panay N, Kalu E. Management of premature ovarian insufficiency. Best Pract. Res. Clin. Obstet. Gynaecol.23(1), 129–140 (2009).
   PubMed Web of Science ®Google Scholar
• Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet. Gynecol.109(6), 1404–1410 (2007).
   PubMed Web of Science ®Google Scholar
• Mamas L, Mamas E. Premature ovarian insufficiency and dehydroepiandrosterone. Fertil. Steril.91(2), 644–646 (2009).
   PubMed Web of Science ®Google Scholar
• Takamizawa S, Shibahara H, Shibayama T, Suzuki M. Detection of antizona pellucida antibodies in the sera from premature ovarian insufficiency patients by a highly specific test. Fertil. Steril.88(4), 925–932 (2007).
   Google Scholar
• Liu L, Rajareddy S, Reddy P et al. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a.Development134(1), 199–209 (2007).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol.22, 531–562 (2004).
   PubMed Web of Science ®Google Scholar
• Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. α-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr. Rev.29(5), 581–602 (2008).
   PubMed Web of Science ®Google Scholar
• Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev.56(1), 1–29 (2004).
   PubMed Web of Science ®Google Scholar
• Catania A. The melanocortin system in leukocyte biology. J. Leukoc. Biol.81, 383–392 (2007).
   Google Scholar
• Han D, Tian Y, Zhang M, Zhou Z, Lu J. Prevention and treatment of experimental auto-immune encephalomyelitis with recombinant adeno-associated virus-mediated α-melanocyte-stimulating hormone-transduced PLP139–151-specific T cells. Gene Ther.14(5), 383–395 (2007).
   Google Scholar
• Yamamoto T, Nishioka K. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp. Dermatol.14(2), 81–95 (2005).
   PubMed Web of Science ®Google Scholar
• Jung EJ, Han DJ, Chang SH et al. Protective effect of α-melanocyte-stimulating hormone on pancreas islet cell against peripheral blood mononuclear cell-mediated cytotoxicity in vitro.Transplant. Proc.39(5), 1604–1606 (2007).
   Google Scholar
• Al-Majed HT, Jones PM, Persaud SJ et al. ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans. J. Endocrinol.180(1), 155–166 (2004).
   PubMedGoogle Scholar
• Getting SJ. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Ther.111(1), 1–15 (2006).
   PubMedGoogle Scholar
• Yamaoka-Tojo M, Tojo T, Shioi T, Masuda T, Inomata T, Izumi T. Central neurotranspeptide, α-melanocyte-stimulating hormone (α-MSH) is upregulated in patients with congestive heart failure. Intern. Med.45(7), 429–434 (2006).
   Google Scholar
• Kolgazi M, Arbak S, Alican I. The effect of α-melanocyte stimulating hormone on gentamicin-induced acute nephrotoxicity in rats. J. Appl. Toxicol.27(2), 183–188 (2007).
   PubMedGoogle Scholar
• Sharma HS. Neuroprotective effects of neurotrophins and melanocortins in spinal cord injury: an experimental study in the rat using pharmacological and morphological approaches. Ann. NY Acad. Sci.1053, 407–421 (2005).
   PubMedGoogle Scholar
• Tatro JB. Melanocortins defend their territory: multifaceted neuroprotection in cerebral ischemia. Endocrinology147(3), 1122–1125 (2006).
   Google Scholar
• Forslin Aronsson S, Spulber S, Popescu LM et al. α-melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides40(1), 65–75 (2006).
   Google Scholar
• Piatti V, Celis ME, Durando PE. The stimulatory effect of α-melanotropin on progesterone release from rat granulosa cells is inhibited by interleukin-1b and by tumour necrosis factor-α. Acta Physiol. Scand.182(2), 145–149 (2004).
   Google Scholar
• Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides27(4), 921–930 (2006).
   PubMed Web of Science ®Google Scholar
• Sánchez-Borzone ME, Attademo A, Baiardi G, Celis ME. Effect of β-adrenoceptors on the behaviour induced by the neuropeptide glutamic acid isoleucine amide. Eur. J. Pharmacol.568(1–3), 186–191 (2007).
   Google Scholar
• Attademo AM, Sanchez-Borzone M, Lasaga M, Celis ME. Intracerebroventricular injection of neuropeptide EI increases serum LH in male and female rats. Peptides25(11), 1995–1999 (2004).
   Google Scholar
• Attademo AM, Rondini TA, Rodrigues BC, Bittencourt JC, Celis ME, Elias CF. Neuropeptide glutamic acid-isoleucine may induce luteinizing hormone secretion via multiple pathways. Neuroendocrinology83(5–6), 313–324 (2006).
   Google Scholar
• Bittencourt J, Celis ME. Anatomy, function and regulation of neuropeptide EI (NEI). Peptides29(8), 1441–1450 (2008).
   Google Scholar